EG17886A - Process for preparing niflumie acid morpholinoethyl ester diniflumate,used in therapeutics as analgesic and anti-inflammatory - Google Patents

Process for preparing niflumie acid morpholinoethyl ester diniflumate,used in therapeutics as analgesic and anti-inflammatory

Info

Publication number
EG17886A
EG17886A EG252/84A EG25284A EG17886A EG 17886 A EG17886 A EG 17886A EG 252/84 A EG252/84 A EG 252/84A EG 25284 A EG25284 A EG 25284A EG 17886 A EG17886 A EG 17886A
Authority
EG
Egypt
Prior art keywords
niflumie
analgesic
therapeutics
inflammatory
preparing
Prior art date
Application number
EG252/84A
Other languages
English (en)
Original Assignee
Hexachimie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexachimie filed Critical Hexachimie
Application granted granted Critical
Publication of EG17886A publication Critical patent/EG17886A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
EG252/84A 1983-04-21 1984-04-21 Process for preparing niflumie acid morpholinoethyl ester diniflumate,used in therapeutics as analgesic and anti-inflammatory EG17886A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8306579A FR2544718B1 (fr) 1983-04-21 1983-04-21 Diniflumate d'ester morpholinoethylique d'acide niflumique, preparation, utilisation en therapeutique comme analgesique et anti-inflammatoire

Publications (1)

Publication Number Publication Date
EG17886A true EG17886A (en) 1991-03-30

Family

ID=9288097

Family Applications (1)

Application Number Title Priority Date Filing Date
EG252/84A EG17886A (en) 1983-04-21 1984-04-21 Process for preparing niflumie acid morpholinoethyl ester diniflumate,used in therapeutics as analgesic and anti-inflammatory

Country Status (26)

Country Link
US (1) US4595686A (xx)
EP (1) EP0129449B1 (xx)
JP (1) JPS59199676A (xx)
KR (1) KR880001477B1 (xx)
AR (1) AR240314A1 (xx)
AT (1) ATE33639T1 (xx)
AU (1) AU561210B2 (xx)
CA (1) CA1218064A (xx)
DE (1) DE3470534D1 (xx)
DK (1) DK157858C (xx)
EG (1) EG17886A (xx)
ES (1) ES531679A0 (xx)
FR (1) FR2544718B1 (xx)
GB (1) GB2140008B (xx)
GR (1) GR81476B (xx)
HU (1) HU194877B (xx)
IE (1) IE57219B1 (xx)
IL (1) IL71525A (xx)
MA (1) MA20097A1 (xx)
MY (1) MY100483A (xx)
NZ (1) NZ207913A (xx)
PH (1) PH18986A (xx)
PT (1) PT78432B (xx)
SG (1) SG107587G (xx)
YU (1) YU65784A (xx)
ZA (1) ZA842672B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192724A (en) * 1992-03-17 1993-03-09 Phillips Petroleum Company Reactivation of spent cracking catalysts
GB0006897D0 (en) * 2000-03-23 2000-05-10 Smithkline Beecham Plc Medicaments
ATE445838T1 (de) 2001-07-25 2009-10-15 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
EP2671508B1 (en) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-informatics system
CA2663377A1 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
HUE059078T2 (hu) 2009-02-20 2022-10-28 Enhanx Biopharm Inc Glutation-alapú hatóanyagszállító rendszer
JP2012526144A (ja) 2009-05-06 2012-10-25 ラボラトリー スキン ケア インコーポレイテッド 活性物質−リン酸カルシウム粒子複合体を含む経皮送達組成物およびその使用方法
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US27822A (en) * 1860-04-10 Isaac mott
GB1146459A (en) * 1966-11-14 1969-03-26 American Cyanamid Co Nicotinic acid derivatives and method of preparing the same
GB1187259A (en) * 1967-10-23 1970-04-08 Hexachimie New Aminoalkyl Esters of 2-Anilino-Nicotinic Acids and process for their manufacture
USRE27822E (en) 1971-07-06 1973-11-27 Substituted phenoxy-z-hydroxy- j-isopropylamino-propanes
DE2601548C2 (de) * 1976-01-16 1984-01-26 Hoechst Ag, 6230 Frankfurt 2-[4-(2'-Chlor-4'-bromphenoxy)-phenoxy]-propionsäure und Derivate sowie diese enthaltende herbizide Mittel
AR208619A1 (es) * 1976-09-02 1977-02-15 Bago Sa Labor Un procedimiento para la obtencion de 2(3'-trifluormetilanilino)nicotinato de 5-hidroxi-6-metil-3,4-piridina dimetano
US4386090A (en) * 1980-12-22 1983-05-31 Delalande S.A. Nitrogen containing 2,3-dihydro naphthalenes, compositions and use
IT1150194B (it) * 1982-02-23 1986-12-10 Chiesi Farma Spa Formulazioni farmaceutiche ad attivita'antiinfiammatoria, analgesica,antipiretica e gastroprotettiva

Also Published As

Publication number Publication date
US4595686A (en) 1986-06-17
KR880001477B1 (ko) 1988-08-13
ATE33639T1 (de) 1988-05-15
DE3470534D1 (en) 1988-05-26
PT78432B (fr) 1986-05-27
HU194877B (en) 1988-03-28
AU561210B2 (en) 1987-04-30
PH18986A (en) 1985-11-29
AR240314A1 (es) 1990-03-30
YU65784A (en) 1986-10-31
DK157858B (da) 1990-02-26
ES8502111A1 (es) 1984-12-16
HUT34188A (en) 1985-02-28
FR2544718A1 (fr) 1984-10-26
DK157858C (da) 1990-07-30
IL71525A0 (en) 1984-07-31
IE57219B1 (en) 1992-06-03
EP0129449B1 (fr) 1988-04-20
DK200884D0 (da) 1984-04-18
CA1218064A (en) 1987-02-17
GB2140008B (en) 1986-11-12
IE840843L (en) 1984-10-21
NZ207913A (en) 1986-11-12
EP0129449A1 (fr) 1984-12-27
KR840008359A (ko) 1984-12-14
GB2140008A (en) 1984-11-21
MA20097A1 (fr) 1984-12-31
AU2674884A (en) 1984-10-25
FR2544718B1 (fr) 1985-12-20
GB8409104D0 (en) 1984-05-16
ES531679A0 (es) 1984-12-16
IL71525A (en) 1987-11-30
JPS59199676A (ja) 1984-11-12
SG107587G (en) 1988-05-20
ZA842672B (en) 1984-11-28
GR81476B (xx) 1984-12-11
DK200884A (da) 1984-10-22
MY100483A (en) 1990-10-15
PT78432A (fr) 1984-05-01

Similar Documents

Publication Publication Date Title
DE3362095D1 (en) Process for producing terephthalic acid suitable for use in direct polymerization
SG52088G (en) Novel pharmaceutical composition based on valproic acid and its production process
HUT35641A (en) Process for preparing 1-benzyl-amino-alkyl-pirrolidinones and acid addition salts thereof
EP0243012A3 (en) Pyridyl-acrylic acid ester derivatives, process for their preparation and their use as fungicides
GB2177089B (en) Thiazolidinecarboxylic acid derivatives and process for preparing same
EG17886A (en) Process for preparing niflumie acid morpholinoethyl ester diniflumate,used in therapeutics as analgesic and anti-inflammatory
DE3067284D1 (en) Carboxylic acid glycidyl esters, process for their preparation and their use in resin compositions
EP0146859A3 (en) Process for preparing but-3-ene-1-carboxylic acids substituted in position 4, and their esters
HUT41033A (en) Process for producing 7-amino-3-propenyl-cephalosporanic acid and esters
DE3364927D1 (en) 2-oxo-1-azetidinesulfonic acid derivatives, process for production thereof, and use thereof
HUT37151A (en) Process for producing 7-beta-amino- and 7-beta-acyl-amino-3-substituted-methyl-3-cepheme-4-carboxylic acid derivatives and for deoxidizing 7-beta-acyl-amino-3-cepheme-4-carboxylic acid-oxide derivatives
IL61179A (en) 2-amino-4-substituted-5-thiazole-carboxylic acid derivatives and process for their preparation
ZA801167B (en) Azole-substituted atropic acid derivatives,process for their manufacture and their use as plant prtecting agents
DE3374695D1 (en) L-2-hydroxy-4-methylpentanoic acid dehydrogenase, process for its production and its use
HUT37403A (en) Process for the production of 2- //1-carbamoil-1,2-dimethyl-propyl/-carbamoyl/-3-quinoline-carboxylic acid,nicotinic acid and benzoic acid substituted in given case
CY1485A (en) Benzothienylallylamines process for their production and their use as pharmaceuticals
DE3564680D1 (en) Gamma-aminobutyric acid derivatives, process for production thereof, and use thereof as medicaments
ZA847640B (en) Cinnamoic compounds,process for preparing same and use in therapeutics
EP0204286A3 (en) Process for preparing trans-beta-benzoylacrylic acid ester
CS415091A3 (en) 2-carbamoyloxymethyl-6-hydroxyethyl-2-penem-3-carboxylic acid ester and process for preparing thereof
ZA835056B (en) New naphtalenic aminoalkyl derivatives,the acid addition salts thereof and the process for preparing same,as well as the application in therapeutics of these derivatives and salts
ZA826121B (en) Process for preparing alkoxy-vincaminic acid esters and alkoxyapovincaminic acid esters
YU326080A (en) Process for reducing the phenylalanine content in proteine hydrolysates
DE3571616D1 (en) 5-halo-4h-1,3-dioxin-4-one compounds, process for their preparation and their use in the preparation of alpha-halo-acetoacetic esters
ZA804079B (en) Dihydronicotinic acid derivatives and process for the preparation thereof